Association of V89L SRD5A2 Polymorphism With Prostate Cancer Development in a Japanese Population
- 1 June 2003
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 169 (6) , 2378-2381
- https://doi.org/10.1097/01.ju.0000056152.57018.31
Abstract
Purpose: The SRD5A2 gene codes the steroid 5-reductase type II, a critical mediator of androgen action, and the V89L and A49T polymorphisms of this gene may be associated with a distinct en...Keywords
This publication has 11 references indexed in Scilit:
- Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450(CYP17) and steroid 5?-reductase type II(SRD5A2) genes on prostate-cancer risk among the Japanese populationInternational Journal of Cancer, 2001
- A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in FinlandBritish Journal of Cancer, 2001
- V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progressionUrology, 2001
- Biochemical and pharmacogenetic dissection of human steroid 5??-reductase type IIPharmacogenetics, 2000
- Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)Carcinogenesis: Integrative Cancer Research, 1999
- Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USAThe Lancet, 1999
- Molecular genetics of steroid 5 alpha-reductase 2 deficiency.Journal of Clinical Investigation, 1992
- 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black malesThe Lancet, 1992
- Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases.Proceedings of the National Academy of Sciences, 1990
- 3 Changing concepts of active androgens in bloodClinics in Endocrinology and Metabolism, 1986